Associations between psychopathology and gender, duration of MS, disability and therapy with beta-interferons were studied in multiple sclerosis (MS) outpatients. A controlled descriptive epidemiological study was carried out in two Italian outpatient MS centres on 50 outpatients with clinically definite relapsing-remitting MS presenting for regular follow-up and 50 healthy controls matched for sex, age and educational level. Subjects were assessed with the Structured Clinical Interview for DSM-IV (SCID I), the Beck Depression Inventory (BDI) and the State Trait Anxiety Inventory (STAI). MS patients reported a higher prevalence of psychiatric disorders (odds ratio 3.17), with 46\% (n=23) suffering from major depressive disorder. The risk of suffering from any non-mood psychiatric disorder was also higher in MS patients than in controls (odds ratio 2.67). Risk factors for depression were female sex and severity of disability, but not therapy with interferon beta or longer duration of illness. Disability level, but not therapy with beta-interferons, is a risk factor for depression in MS outpatients. Regular screening for depression in this population is appropriate.

Psychiatric disorders and depression in multiple sclerosis outpatients: Impact of disability and interferon beta therapy / Galeazzi, Gian Maria; Ferrari, Silvia; Giaroli, Giovanni; Mackinnon, Andrew; Merelli, Elisa; Motti, L; Rigatelli, Marco. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - STAMPA. - 26:(2005), pp. 255-262. [10.1007/s10072-005-0468-8]

Psychiatric disorders and depression in multiple sclerosis outpatients: Impact of disability and interferon beta therapy

GALEAZZI, Gian Maria;FERRARI, Silvia;RIGATELLI, Marco
2005

Abstract

Associations between psychopathology and gender, duration of MS, disability and therapy with beta-interferons were studied in multiple sclerosis (MS) outpatients. A controlled descriptive epidemiological study was carried out in two Italian outpatient MS centres on 50 outpatients with clinically definite relapsing-remitting MS presenting for regular follow-up and 50 healthy controls matched for sex, age and educational level. Subjects were assessed with the Structured Clinical Interview for DSM-IV (SCID I), the Beck Depression Inventory (BDI) and the State Trait Anxiety Inventory (STAI). MS patients reported a higher prevalence of psychiatric disorders (odds ratio 3.17), with 46\% (n=23) suffering from major depressive disorder. The risk of suffering from any non-mood psychiatric disorder was also higher in MS patients than in controls (odds ratio 2.67). Risk factors for depression were female sex and severity of disability, but not therapy with interferon beta or longer duration of illness. Disability level, but not therapy with beta-interferons, is a risk factor for depression in MS outpatients. Regular screening for depression in this population is appropriate.
2005
26
255
262
Psychiatric disorders and depression in multiple sclerosis outpatients: Impact of disability and interferon beta therapy / Galeazzi, Gian Maria; Ferrari, Silvia; Giaroli, Giovanni; Mackinnon, Andrew; Merelli, Elisa; Motti, L; Rigatelli, Marco. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - STAMPA. - 26:(2005), pp. 255-262. [10.1007/s10072-005-0468-8]
Galeazzi, Gian Maria; Ferrari, Silvia; Giaroli, Giovanni; Mackinnon, Andrew; Merelli, Elisa; Motti, L; Rigatelli, Marco
File in questo prodotto:
File Dimensione Formato  
MS_Galeazzi_2005.pdf

Solo gestori archivio

Tipologia: Versione pubblicata dall'editore
Dimensione 75.02 kB
Formato Adobe PDF
75.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/596352
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 101
  • ???jsp.display-item.citation.isi??? 87
social impact